PIERIS PHARMACEUTICALS, INC. Quarterly Current Ratio in % from Q3 2015 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Pieris Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q4 2023.
  • Pieris Pharmaceuticals, Inc. Current Ratio for the quarter ending December 31, 2023 was 190 %, a 22.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 190 -53.9 -22.1% Dec 31, 2023
Q3 2023 182 -75.1 -29.2% Sep 30, 2023
Q2 2023 189 -77.6 -29.1% Jun 30, 2023
Q1 2023 204 -70.5 -25.7% Mar 31, 2023
Q4 2022 244 -31.5 -11.4% Dec 31, 2022
Q3 2022 257 -37 -12.6% Sep 30, 2022
Q2 2022 267 -60.9 -18.6% Jun 30, 2022
Q1 2022 275 -107 -28% Mar 31, 2022
Q4 2021 276 -164 -37.4% Dec 31, 2021
Q3 2021 294 -167 -36.3% Sep 30, 2021
Q2 2021 328 -54.2 -14.2% Jun 30, 2021
Q1 2021 381 +51.8 +15.7% Mar 31, 2021
Q4 2020 440 +139 +46.1% Dec 31, 2020
Q3 2020 461 +185 +67.1% Sep 30, 2020
Q2 2020 382 +78.6 +25.9% Jun 30, 2020
Q1 2020 330 +20.5 +6.62% Mar 31, 2020
Q4 2019 301 -7.64 -2.47% Dec 31, 2019
Q3 2019 276 -13.1 -4.54% Sep 30, 2019
Q2 2019 303 +38.8 +14.7% Jun 30, 2019
Q1 2019 309 +50.4 +19.5% Mar 31, 2019
Q4 2018 309 +46.6 +17.7% Dec 31, 2018
Q3 2018 289 -16.7 -5.46% Sep 30, 2018
Q2 2018 265 -94.3 -26.3% Jun 30, 2018
Q1 2018 259 -229 -46.9% Mar 31, 2018
Q4 2017 262 -226 -46.2% Dec 31, 2017
Q3 2017 306 -285 -48.2% Sep 30, 2017
Q2 2017 359 -446 -55.4% Jun 30, 2017
Q1 2017 487 -291 -37.4% Mar 31, 2017
Q4 2016 488 -418 -46.1% Dec 31, 2016
Q3 2016 590 -149 -20.1% Sep 30, 2016
Q2 2016 805 Jun 30, 2016
Q1 2016 778 Mar 31, 2016
Q4 2015 906 Dec 31, 2015
Q3 2015 739 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.